Age Restrictions on Indoor Tanning Reduces Melanoma Cases and Costs

December 22, 2016

If individuals were limited to indoor tanning based on age, the number of melanoma cases, costs of treatment and deaths from the disease could decrease.
This information is supported by results from an economic analysis about this subject were published in the Journal of the American Academy of Dermatology. The study’s author, Gery P. Guy, Ph.D., MPH, health economist in the CDC Division of Cancer Prevention and Control’s Epidemiology and Applied Research Branch Minors, supports this information as well. 
Individuals under the age of 18 were restricted from indoor tanning after the U. S. Food and Drug Administ­ration proposed an age limit in December 2015.
Estimating the Benefits
Guy and his colleagues tested five scenarios to estimate:
The team looked at restricting indoor tanning for minors under age 18 in addition to reducing the prevalence by 20%, 50%, 80% and 100%.  
Read more at Skin Inc. Magazine >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Dermalogica Launches FDA-Cleared PRO Pen Microneedling System
    • Regenerative Aesthetics Is Evolving. Are You Keeping Up?
    • Influx Marketing Introduces Growthstack, a New All-In-One Growth Platform Built for Med Spas
    • AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE
    • ByrdAdatto Named to D Magazine’s 2026 Best Lawyers in Dallas List